Adaptive Biotechnologies Corp's stock plummeted 6.31% during intraday trading on Friday, reflecting a sharp decline in investor sentiment.
The movement appears to be driven by analyst commentary on the company, as part of broader insights on healthcare stocks. The specific analyst views, likely cautious or negative, prompted the sell-off.